Cargando…
SOX1 and PAX1 Are Hypermethylated in Cervical Adenocarcinoma and Associated with Better Prognosis
BACKGROUND: The increased risk and poor survival outcome of cervical adenocarcinoma (CAC) demand for effective early diagnostic biomarkers that can predict the disease progression and outcome. The purpose of this study was to investigate the value of methylation status of SOX1 and PAX1 in the detect...
Autores principales: | Zhao, Zitong, Zhang, Xiaoye, Zhao, Xueheng, Cai, Jingting, Wu, Na-Yi Yuan, Wang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738792/ https://www.ncbi.nlm.nih.gov/pubmed/33376722 http://dx.doi.org/10.1155/2020/3981529 |
Ejemplares similares
-
DNA hypermethylated status and gene expression of PAX1/SOX1 in patients with colorectal carcinoma
por: Huang, Jin, et al.
Publicado: (2017) -
SOX14 hypermethylation as a tumour biomarker in cervical cancer
por: Zhao, Jing, et al.
Publicado: (2021) -
PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study
por: Lai, Hung-Cheng, et al.
Publicado: (2014) -
Hypermethylation of SOX2 Promoter in Endometrial Carcinogenesis
por: Wong, Oscar Gee-Wan, et al.
Publicado: (2010) -
Tumor-suppressor gene SOX1 is a methylation-specific expression gene in cervical adenocarcinoma
por: Yuan, Min, et al.
Publicado: (2019)